Figure 7. Forest plot showing MIDAS between galcanezumab and placebo groups before (A) and after (B) sensitivity analysis using the leave-one-out method.
MIDAS, migraine disability assessment score
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.